While our previous study demonstrated that loss of transient receptor potential ankyrin 1 (
Trpa1
) accelerates age-related cardiac fibrosis in mice, the underlying mechanism of potential anti-fibrotic property of TRPA1 remains largely unknown. TRPA1 is a sensor of oxidative stress and may play a protective role in age-related diseases. In this study, we performed quantitative polymerase chain reaction array analyses of the mRNA expression of 84 fibrosis-related genes in the myocardial tissue of 12-month-old
Trpa1
-/-
mice with significant cardiac fibrosis and age-matched wild-type mice without cardiac fibrosis. The mRNA levels of
Col1a2
and
Col3a1
in the myocardial tissue were similar between
Trpa1
-/-
and wild-type mice, suggesting comparable cardiac collagen synthesis in the two strains. Matrix metalloproteinases are major enzymes responsible for degradation of collagen fibers. The results show that the mRNA levels of matrix metalloproteinases, including
Mmp1a
,
Mmp2
,
Mmp3
,
Mmp8
,
Mmp9
,
Mmp13
, and
Mmp14
, in the heart were similar between
Trpa1
-/-
and wild-type mice. Nevertheless, we identified 7 significantly changed genes in the heart between the two strains. The expression levels of
Acta2
,
Inhbe
,
Ifng
, and
Ccl11
were significantly increased with fold changes of 3.1, 1.9, 1.9, and 1.5 (all
P
< 0.05), respectively, while
Timp3
,
Stat6
, and
Ilk
were significantly decreased with fold changes of 0.3, 0.5, and 0.7 (all
P
< 0.05), respectively, in the heart of
Trpa1
-/-
mice compared with wild-type mice.
Acta2
, the most upregulated gene in
Trpa1
-/-
hearts, is a marker of myofibroblasts. Its upregulation indicates increased differentiation from fibroblasts into myofibroblasts in
Trpa1
-/-
hearts compared with wild-type hearts.
Timp3
, the most downregulated gene in
Trpa1
-/-
hearts, codes an extracellular matrix protein TIMP3, which not only inhibits matrix metalloproteinases but also regulate post-translational modification of collagen fibers. Taken together, these findings suggest that upregulation of
Acta2
and downregulation of
Timp3
may serve as genetic signature or play a role in accelerated age-related cardiac fibrosis due to TRPA1 ablation.